Clinical Trial: A Study in Type 2 Diabetes Patients Who Are Taking Moderate Dose Insulin, Looking at the Effects of the Medication Luseogliflozin on Risk of Ketoacidosis and Insulin Resistance.

U.S., Oct. 16 -- ClinicalTrials.gov registry received information related to the study (NCT07876258) titled 'A Study in Type 2 Diabetes Patients Who Are Taking Moderate Dose Insulin, Looking at the Effects of the Medication Luseogliflozin on Risk of Ketoacidosis and Insulin Resistance.' on Oct. 03.

Brief Summary: The goal of this clinical trial is to learn if the drug Luseogliflozin works to treat people with diabetes who are taking moderate dose insulin treatment. It will also learn about the safety of the drug Luseogliflozin. The main questions it aims to answer are:

Does Luseogliflozin improve the sugar control of people with diabetes by lowering the insulin resistance numbers in each participants?

What is the likelihood of participan...